Synergy CHC Corp. earnings releases SNYRQ

Annual Quarterly

Synergy CHC Corp. last reported quarterly results on May 14, 2026, for Q1 FY2026 (the quarter ended Mar 31, 2026): revenue of $5.5 million (-32.8% year over year) and diluted EPS of -$0.23. It usually reports 44–45 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 44–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
May 14, 2026
44 days after quarter end
Q1 FY2026
ended Mar 31, 2026
5
-32.8%
-3
-393.2%
-0.23
-330.0%
Nov 13, 2025
44 days after quarter end
Q3 FY2025
ended Sep 30, 2025
8
+12.4%
0
-84.0%
0.01
-90.9%
Aug 14, 2025
45 days after quarter end
Q2 FY2025
ended Jun 30, 2025
8
1
0.17
May 15, 2025
45 days after quarter end
Q1 FY2025
ended Mar 31, 2025
8
1
0.10
Dec 6, 2024
67 days after quarter end
Q3 FY2024
ended Sep 30, 2024
7
1
0.11

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
SNYRQ (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Westbrook, ME
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1562733
Former names
Synergy Strips Corp. (until Aug 6, 2015); Oro Capital Corporation, Inc. (until Apr 24, 2014)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.